None listed
Conditions
Brief summary
Cardiac amyloidosis (CA) is characterized by extracellular deposition of misfolded proteins that causes increased heart thickness. Exercise intolerance is among the most common complaints expressed by patients with cardiac amyloidosis due to poor cardiac performance. The aim of our study was to test whether chronotropic incompetence, and abnormal heart rate recovery would be associated with impaired aerobic capacity in ATTR patients with cardiac involvement.
Interventions
a) Lung function test and cardiopulmonary exercise testing will be performed on the same day. Typically, lung function tests will be performed before exercise testing b) Testing will be performed once at patients inclusion. Duration of lung function evaluation is 45 min and duration of cardiopulmonary exercise testing is 60 min. c) Doctors (cardiologists) will be involved in lung function test and cardiopulmonary exercise testing as well. d) Lung function test includes spirometry and lung plethysmography. Cardiopulmonary exercise testing includes measures of ventilation and respiratory gas parameters during cycling exercise. Measuring systems relies on breath-by-breath analysis techniques. Oxygen and carbon dioxide gas analyzers are usually incorporated in a “metabolic cart” designed specifically for functional testing. Respiratory volumes are computed by integrating the air flow signals over the time of inspiration and expiration. Average minute volumes are derived from the breath-by-breath data multiplied by the respiratory rate
Sponsors
Eligibility
Inclusion criteria
Afro-Caribbean patients with mutant transthyretin amyloid cardiomyopathy
Exclusion criteria
coronary artery disease unable to perform cycling altered mental status